research-focus Research Focus International Scientific Journal Research Focus 2181-3833 Ilm-fan va innovatsiyalar akademiyasi 10.66073/researchfocus.v3i10.1114 REL-A-012616 14.00.00 IMPACT OF ANTIBIOTIC RESISTANCE ON HEALTHCARE OUTCOMES ВЛИЯНИЕ УСТОЙЧИВОСТИ К АНТИБИОТИКАМ НА РЕЗУЛЬТАТЫ ЛЕЧЕНИЯ ANTIBIOTIKLARGA CHIDAMLILIKNING SOG‘LIQNI SAQLASH NATIJALARIGA TA‘SIRI Imran Aslam Research Assistant & Assistant Professor, Department of Pharmacology Samarkand State Medical University Ayesha Ashraf Assistant Professor, Department of Public Health Samarkand State Medical University 05 11 2024 2024 3 10 131 138 https://creativecommons.org/licenses/by/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.

Antibiotic resistance (ABR) has arisen as a critical concern in contemporary healthcare, significantly impacting patient outcomes, healthcare systems, and worldwide public health. As bacteria develop resistance to widely utilized antibiotics, infections become progressively challenging to manage, leading to prolonged hospitalizations, elevated treatment expenses, and heightened morbidity and fatality rates. This study examines the effects of ABR on healthcare outcomes, encompassing clinical, economic, and systemic difficulties it poses. The paper emphasizes the significance of antimicrobial stewardship programs in alleviating these consequences and offers recommendations for improving existing hospital policies and procedures.

Устойчивость к антибиотикам (ABR) стала серьезной проблемой в современном здравоохранении, существенно влияя на результаты лечения пациентов, системы здравоохранения и мировое общественное здравоохранение. Поскольку бактерии развивают устойчивость к широко используемым антибиотикам, инфекции становятся все более сложными для лечения, что приводит к длительным госпитализациям, повышенным расходам на лечение и повышенным показателям заболеваемости и смертности. В этом исследовании изучается влияние ABR на результаты лечения, охватывая клинические, экономические и системные трудности, которые оно создает. В статье подчеркивается важность программ управления противомикробными препаратами для смягчения этих последствий и предлагаются рекомендации по улучшению существующих больничных политик и процедур.

Antibiotiklarga chidamlilik (ABR) zamonaviy sog‘liqni saqlash tizimida jiddiy muammo sifatida yuzaga chiqdi va bemorlarni davolash natijalariga, sog‘liqni saqlash tizimlariga hamda jahon jamoat salomatligiga sezilarli ta‘sir ko‘rsatmoqda. Bakteriyalar keng qo‘llaniladigan antibiotiklarga chidamlilik hosil qilgani sari infeksiyalarni davolash tobora murakkablashib bormoqda, bu esa gospitalizatsiya muddatining uzayishiga, davolash xarajatlarining ortishiga hamda kasallanish va o‘lim ko‘rsatkichlarining oshishiga olib keladi. Ushbu tadqiqotda ABRning davolash natijalariga ta‘siri, u keltirib chiqaradigan klinik, iqtisodiy va tizimli qiyinchiliklarni qamrab olgan holda o‘rganiladi. Maqolada bu oqibatlarni yumshatishda antimikrob preparatlardan oqilona foydalanish dasturlarining ahamiyati ta‘kidlanadi va mavjud shifoxona siyosati hamda tartib-qoidalarini takomillashtirish bo‘yicha tavsiyalar beriladi.

 Antibiotic resistance healthcare outcomes antimicrobial stewardship programs hospital stays treatment costs mortality rates infection complications public health Устойчивость к антибиотикам результаты лечения программы управления противомикробными препаратами пребывание в больнице расходы на лечение показатели смертности осложнения инфекций общественное здравоохранение Antibiotiklarga chidamlilik sog‘liqni saqlash natijalari antimikrob preparatlarni oqilona qo‘llash dasturlari kasalxonada yotish muddati davolash xarajatlari o‘lim ko‘rsatkichlari infeksiya asoratlari jamoat salomatligi Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., ... & Trivedi, K. K. (2016). Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, 62(10), e51-e77. Baxter, C. G., Russell, C., Duncan, H., Farrell, S., Law, S., Baker, J., & Denning, D. W. (2016). Clinical and laboratory features of invasive aspergillosis and the significance of aspergillus in respiratory samples in acute leukaemia and haematopoietic stem cell transplantation. British Journal of Haematology, 139(3), 504-515. Centers for Disease Control and Prevention (2019). Antibiotic resistance threats in the United States. Retrieved from https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats- report-508.pdf Cosgrove, S. E., & Carmeli, Y. (2003). The impact of antimicrobial resistance on health and economic outcomes. Clinical Infectious Diseases, 36(11), 1433-1437. Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., ... & Hooton, T. M. (2007). Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases, 44(2), 159-177. Dyar, O. J., Huttner, B., Schouten, J., & Pulcini, C. (2017). What is antimicrobial stewardship? Clinical Microbiology and Infection, 23(11), 793-798. Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., ... & Piddock, L. J. V. (2016). Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet, 387(10014), 176-187. Aslam, I., & Jiyanboyevich, Y. S. (2023). THE COMMON PROBLEM OF INTERNATIONAL STUDENTS AND ITS SOLUTION AND UNEXPECTED CHALLENGES OF WORKING WITH FOREIGN TEACHER. Internationalization of Medical Education: Experience, Problems, Prospects, 66. Jiyanboevich, Y. S., Aslam, I., & Soatboyevich, J. N. (2024). FAILURE OF THE HEART DETERMINATION PROTEOMIC PROFILING RELATED TO PATIENTS WHO ARE ELDERLY. Research Focus, 3(1), 198-203. Nodirovna, A. R., Maksudovna, M. M., Aslam, I., & Ergashboevna, A. Z. (2024). Evaluating Novel Anticoagulant and Antiplatelet Drugs for Thromboembolic Illness Prevention and Treatment. International Journal of Alternative and Contemporary Therapy, 2(5), 135-141. Shahzoda, K., Aslam, I., Ashraf, A., Ergashboevna, A. Z., & Ergashboevna, E. M. (2024). ADVANCEMENTS IN SURGICAL TECHNIQUES: A COMPREHENSIVE REVIEW. Ta'limda raqamli texnologiyalarni tadbiq etishning zamonaviy tendensiyalari va rivojlanish omillari, 31(2), 139-149. Aslam, I., & Jiyanboyevich, Y. S. (2023). THE COMMON PROBLEM OF INTERNATIONAL STUDENTS AND ITS SOLUTION AND UNEXPECTED CHALLENGES OF WORKING WITH FOREIGN TEACHER. Internationalization of Medical Education: Experience, Problems, Prospects, 66. Nodirovna, A. R., Maksudovna, M. M., Aslam, I., & Ergashboevna, A. Z. (2024). Evaluating Novel Anticoagulant and Antiplatelet Drugs for Thromboembolic Illness Prevention and Treatment. International Journal of Alternative and Contemporary Therapy, 2(5), 135-141. Aslam, I., Jiyanboevich, Y. S., & Rajabboevna, A. R. (2023). Apixaban vs Rivaroxaban Blood Thinner Use Reduced Stroke and Clot Risk in Patients with Heart Disease and Arrhythmia. Rivista Italiana di Filosofia Analitica Junior, 14(2), 883-889. Aslam, I., Jiyanboevich, Y. S., & Rajabboevna, A. R. (2023). Apixaban vs Rivaroxaban Blood Thinner Use Reduced Stroke and Clot Risk in Patients with Heart Disease and Arrhythmia. Rivista Italiana di Filosofia Analitica Junior, 14(2), 883-889.